Robert DeSantis - 15 Feb 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: EVP & Chief Product Officer
Signature: By: Donna Spinola For: DeSantis, Robert
Issuer symbol: ISRG
Transactions as of: 15 Feb 2023
Net transactions value: -$637,574
Form type: 4
Filing time: 16 Feb 2023, 17:45:32 UTC
Previous filing: 30 Jan 2023
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$0	+2,124	+31%	$0.000000	9,002	15 Feb 2023	Direct	F1
transaction	ISRG	Common Stock	Tax liability	$163,017	-666	-7.4%	$244.77	8,336	15 Feb 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$474,558	-1,971	-24%	$240.77	6,365	16 Feb 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Restricted Stock Units	Options Exercise	$0	-2,124	-100%	$0.000000^*	0	15 Feb 2023	Common Stock	2,124	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25 % of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
F2	These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.
F3	Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.